(Q40753314)

23 September 2017

1 reference

title

The cholecystokinin hypothesis of anxiety and panic disorder (English)

1 reference

23 September 2017

1 reference

Bradwejn J

1

1 reference

23 September 2017

Koszycki D

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

Annals of the New York Academy of Sciences

23 September 2017

published in

1 reference

23 September 2017

volume

713

1 reference

23 September 2017

page(s)

273-282

1 reference

Life events preceding the onset of panic disorder.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Quality of life in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

The prevalence of anxiety disorders among patients with mitral valve prolapse syndrome and chest pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Irritable bowel syndrome and psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Migraine headaches and panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Panic disorder, comorbidity, and suicide attempts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Substance abuse and panic-related anxiety: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Relationship between panic disorder and agoraphobia. A family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Panic disorder: genetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Genetic factors in anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Chemical Anatomy of the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: a microiontophoretic study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Pharmacologic models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Cholecystokinin-4 and panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Sodium lactate infusions and panic attacks: a review and critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

A nonhuman primate model of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

CCK in animal and human research on anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Role of ventrolateral medulla in vasomotor regulation: a correlative anatomical and physiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Renal sympathetic nerve responses to stimulation, inhibition and destruction of the ventrolateral medulla in the rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

Role of the nucleus parabrachialis in cardiovascular regulation in cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

A neuroanatomical hypothesis for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB44075.X

10.1111/J.1749-6632.1994.TB44075.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference